Market Tracker

04/15 6:05pm ET

Furiex Pharmaceuticals Inc (NASDAQ:FURX)

78.71
Data as of Apr 15
 +1.22 / +1.57%
Today’s Change
32.01
Today|||52-Week Range
121.97
+87.36%
Year-to-Date

Today’s Trading

Previous close77.49
Today’s open77.86
Day’s range75.29 - 80.24
Volume143,214
Average volume (3 months)334,165
Market cap$870.2M
Dividend yield--
Data as of 3:59pm ET, 04/15/2014

Growth & Valuation

Earnings growth (last year)+31.93%
Earnings growth (this year)+31.34%
Earnings growth (next 5 years)+129.00%
Revenue growth (last year)+75.27%
P/E ratioNM
Price/Sales6.00
Price/Book46.52

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc+0.17+0.92%
SRPTSarepta Therapeutics...+0.38+1.70%
EBSEmergent BioSolution...+0.61+2.64%
CBPOChina Biologic Produ...+0.77+2.15%
Data as of 4:02pm ET, 04/15/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$71.0M
Annual profit (last year)-$29.7M
Net profit margin-41.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Chief Medical Officer
June Sherie Almenoff
Senior VP-Clinical Development &
Operations
Paul S. Covington
Corporate headquarters
Morrisville, North Carolina

Forecasts